Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Vertex Pharmaceuticals Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable
Accrued expenses
Other current liabilities
Current liabilities
Long-term operating lease liabilities
Long-term finance lease liabilities
Other long-term liabilities
Long-term liabilities
Total liabilities
Preferred stock, $0.01 par value; none issued
Common stock, $0.01 par value
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Shareholders’ equity
Total liabilities and shareholders’ equity

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


The financial data reveals several notable trends in the liabilities and equity components over the examined periods.

Current Liabilities

Accounts payable demonstrated fluctuations with a general increasing trend, rising from approximately $100.7 million at the start to $445 million by the end of the period, with some interim volatility. Accrued expenses also showed a consistent upward movement from roughly $1.26 billion to about $2.95 billion, indicating growing short-term obligations. Other current liabilities experienced variability but trended upward substantially, peaking at around $648.6 million before moderating somewhat. Overall, current liabilities increased from $1.54 billion to $3.78 billion, reflecting rising short-term financial commitments.

Long-term Liabilities

Long-term operating lease liabilities began being reported from December 2020, initially near $350 million, then exhibited a substantial jump in late 2024 to approximately $1.54 billion, suggesting new lease obligations or reclassifications. Long-term finance lease liabilities declined steadily from about $533 million to $111 million, indicating repayment or settlement of outstanding leases. Other long-term liabilities were variable but mostly increased, reaching near $952 million by the end. Total long-term liabilities demonstrated an increase from around $893 million to $2.60 billion, highlighting a strengthening in long-term obligations.

Total Liabilities

Total liabilities showed a consistent upward trend from approximately $2.43 billion to about $6.38 billion over the timeframe, underscoring an overall rise in the company's obligations. This growth appears driven by both current and long-term liabilities, with marked increases in accrued expenses and lease liabilities contributing significantly.

Shareholders’ Equity

Common stock remained stable around $2.6 million, indicating no significant new issuances or buybacks. Additional paid-in capital fluctuated, peaking near $7.4 billion before decreasing to approximately $6.17 billion, which could reflect share repurchases or other equity adjustments. Accumulated other comprehensive income/loss demonstrated volatility, swinging between gains and losses but showing a positive balance near $68 million at the end. Retained earnings increased substantially from a deficit of about $1.25 billion to a positive balance of over $10.25 billion, indicating sustained profitability or earnings retention. Shareholders’ equity grew overall from about $6.46 billion to approximately $16.50 billion, although a decline in mid-late 2024 suggests possible impacts on equity during that period.

Overall Financial Position

Total liabilities and shareholders’ equity combined increased steadily, from roughly $8.89 billion to nearly $22.88 billion, reflecting growth in the company's capital base and obligations. Notably, the periods around late 2024 show some volatility, particularly in lease liabilities and equity components, which may warrant further investigation. The data suggests expanding operations or investments financed through increased liabilities and equity, with profitability contributing to growing retained earnings.